Jacob Rothschild China Outbound Private Equity Fund

RIT Capital Partners, a British investment fund controlled by Lord Jacob Rothschild, and Chinese investment firm Creat Group plans to set up a $750 million private equity fund in China. The fund will raise most of its money from Chinese companies and then invest in Western businesses in a wide range of sectors including technology, natural resources and luxury goods. RIT and Creat Group will together invest $100 million in this venture.

Zhejiang Hisun Pharma Invests in U.S. Biotech Company

Zhejiang Hisun Pharmaceutical Co. has agreed to invest $5 million in Photolitec LLC, Buffalo, NY, which develops photosensitizing used to identify cancer through medical imaging technology. Zhejiang Hisun Pharmaceutical is listed on the Shanghai Stock Exchange and manufactures active pharmaceutical ingredients as well as pharmaceutical products.

Bright Dairy Makes Highest Offer for Yoplait

China's Bright Dairy & Food has reportedly submitted the highest offer to acquire a 50% stake in Sodiaal which owns the Yoplait yogurt brand, valuing the business at Euro 1.7 billion. The 50% shareholding in Sodiaal is being sold by French private equity group PAI Partners. However it is not yet clear if paying the highest price will be sufficient for Bright Dairy to prevail in this situation.